PLoS By Category | Recent PLoS Articles

Immunology - Public Health and Epidemiology - Rheumatology

Genetic Risk Score Predicting Risk of Rheumatoid Arthritis Phenotypes and Age of Symptom Onset
Published: Monday, September 12, 2011
Author: Lori B. Chibnik et al.

by Lori B. Chibnik, Brendan T. Keenan, Jing Cui, Katherine P. Liao, Karen H. Costenbader, Robert M. Plenge, Elizabeth W. Karlson


Cumulative genetic profiles can help identify individuals at high-risk for developing RA. We examined the impact of 39 validated genetic risk alleles on the risk of RA phenotypes characterized by serologic and erosive status.

Methods/Principal Findings

We evaluated single nucleotide polymorphisms at 31 validated RA risk loci and 8 Human Leukocyte Antigen alleles among 542 Caucasian RA cases and 551 Caucasian controls from Nurses' Health Study and Nurses' Health Study II. We created a weighted genetic risk score (GRS) and evaluated it as 7 ordinal groups using logistic regression (adjusting for age and smoking) to assess the relationship between GRS group and odds of developing seronegative (RF- and CCP-), seropositive (RF+ or CCP+), erosive, and seropositive, erosive RA phenotypes. In separate case only analyses, we assessed the relationships between GRS and age of symptom onset.In 542 RA cases, 317 (58%) were seropositive, 163 (30%) had erosions and 105 (19%) were seropositive with erosions. Comparing the highest GRS risk group to the median group, we found an OR of 1.2 (95% CI?=?0.8–2.1) for seronegative RA, 3.0 (95% CI?=?1.9–4.7) for seropositive RA, 3.2 (95% CI?=?1.8–5.6) for erosive RA, and 7.6 (95% CI?=?3.6–16.3) for seropositive, erosive RA. No significant relationship was seen between GRS and age of onset.


Results suggest that seronegative and seropositive/erosive RA have different genetic architecture and support the importance of considering RA phenotypes in RA genetic studies.